CliffBio
small molecule

SODIUM BICARBONATE

SODIUM BICARBONATE

Loss of exclusivity—loss of exclusivity
CompanyOMNIVIUM PHARMACEUTICALS LLC

Drug detail

Brand nameSODIUM BICARBONATE
Active ingredientSODIUM BICARBONATE
Strength50MEQ/50ML (1MEQ/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2023
Marketing statusRX

More from OMNIVIUM PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SODIUM BICARBONATE patent cliff — loss of exclusivity — | CliffBio